申请人:ALDEXA THERAPEUTICS, INC.
公开号:US20150344432A1
公开(公告)日:2015-12-03
The present invention is directed to compounds of formula(I):
pharmaceutical compositions, and methods of use for treating, reducing a symptom of or reducing the risk of macular degeneration.
本发明涉及式(I)化合物:制药组合物和用于治疗、减轻症状或减少黄斑变性风险的方法。